TY  - GEN
N2  - In this case study, I demonstrate that CHCs are present in the blood of one patient with choroidal melanoma, lung adenocarcinoma, and a neuroendocrine tumor of the lung. Furthermore, I hope to show that CHCs decline following definitive treatment to demonstrate the potential of CHCs as a prognostic biomarker across one patient's treatment journey.
DO  - 10.6083/5425kb477
DO  - DOI
AB  - In this case study, I demonstrate that CHCs are present in the blood of one patient with choroidal melanoma, lung adenocarcinoma, and a neuroendocrine tumor of the lung. Furthermore, I hope to show that CHCs decline following definitive treatment to demonstrate the potential of CHCs as a prognostic biomarker across one patient's treatment journey.
AD  - Oregon Health and Science University
T1  - Circulating neoplastic-immune hybrid cells as biomarkers in one patient with three primary malignancies
ED  - Wong, Melissa H.
ED  - Mozell, Noah W.
ED  - Whalen, Riley M.
ED  - Anderson, Ashley N.
ED  - Fan, Wendy
ED  - Mentor
ED  - Co-PI
ED  - Co-PI
ED  - Co-PI
ED  - Co-PI
DA  - 2023
AU  - Mozell, Noah
L1  - https://digitalcollections.ohsu.edu/record/10095/files/Mozell.Noah.2023.pdf
PB  - Oregon Health and Science University
PY  - 2023
ID  - 10095
L4  - https://digitalcollections.ohsu.edu/record/10095/files/Mozell.Noah.2023.pdf
KW  - Adenocarcinoma
KW  - Neoplastic Cells, Circulating
KW  - Neuroendocrine Tumors
KW  - circulating hybrid cells
KW  - immunofluorescence
KW  - choroidal melanoma
TI  - Circulating neoplastic-immune hybrid cells as biomarkers in one patient with three primary malignancies
Y1  - 2023
L2  - https://digitalcollections.ohsu.edu/record/10095/files/Mozell.Noah.2023.pdf
LK  - https://digitalcollections.ohsu.edu/record/10095/files/Mozell.Noah.2023.pdf
UR  - https://digitalcollections.ohsu.edu/record/10095/files/Mozell.Noah.2023.pdf
ER  -